Immunovia AB, a Swedish diagnostic company, has reported the results of a retrospective study of blood samples from patients with pancreatic cancer which was able to differentiate patients with early cancer from controls with 96% accuracy. ---Subscribe to MedNous to access this article--- Company News Research & University News
